Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Platelet-rich plasma regenerative therapy offers a promising, minimally invasive approach to easing pain during intercourse by using your own blood’s growth factors to promote tissue repair, improve lubrication, and address issues like thinning vaginal lining or pelvic floor dysfunction. Early studies show reduced pain scores and enhanced sexual comfort, but individual outcomes can vary.
There are several factors to consider when evaluating PRP for dyspareunia, including treatment schedules, potential risks, and integration with pelvic floor therapy or topical estrogen. See below for complete information on procedures, candidacy criteria, aftercare, and how to make an informed decision.
Painful intercourse (dyspareunia) affects millions of women worldwide, disrupting intimacy, self-confidence, and overall quality of life. While many causes exist—hormonal changes, pelvic floor dysfunction, scars, or thinning vaginal tissue—regenerative therapies like platelet-rich plasma (PRP) are emerging as promising solutions. Here's what you need to know.
Dyspareunia refers to pain during or after sexual activity. Common causes include:
Traditional treatments often include:
These options help many women, but some still experience persistent pain. That's where regenerative medicine steps in.
Platelet-rich plasma (PRP) harnesses your body's natural healing factors. By concentrating platelets from your own blood and injecting them into targeted tissues, PRP can stimulate cell growth, improve blood flow, and rebuild healthy tissue.
Key benefits of PRP for painful intercourse include:
PRP therapy is not a one-size-fits-all, but it may help women who:
While research is still growing, early studies and clinical reports suggest:
Always seek clinics that abide by established protocols and have trained specialists in women's health regenerative therapies.
PRP is generally safe, but it carries some considerations:
Discuss any bleeding disorders, active infections, or medications that affect clotting with your provider before proceeding.
Maximize your results by integrating:
While PRP is low risk, always speak to a doctor if you experience:
For ongoing or bothersome vaginal symptoms—especially in women over 50—consider using a free Atrophic Vaginitis symptom checker to help identify potential causes.
Regenerative therapy like PRP for painful intercourse offers a novel path toward healing. To decide if it's right for you:
This information is intended to guide and inform but does not replace personalized medical advice. If you have life-threatening or serious symptoms, or if you're considering PRP therapy, please speak to a qualified doctor to discuss your specific needs, treatment options, and any potential risks. Your health and comfort deserve expert attention.
(References)
* Gholamrezaei F, Kariman N, Sahrakar N, Ghasemi F, Rezaei N. Platelet-rich plasma for the treatment of dyspareunia: A systematic review. Complement Ther Clin Pract. 2023 Feb;50:101689. doi: 10.1016/j.ctcp.2022.101689. Epub 2022 Dec 7. PMID: 36528731.
* Rzepka KM, Giraldi A, Ejzenberg D, Goldstein AT, Constantine ML. Regenerative Medicine in Vulvovaginal Health: A Review of the Current Evidence. J Sex Med. 2023 Mar;20(3):362-373. doi: 10.1093/jsxmed/qrad005. PMID: 36724127.
* Al-Qattan S, Gholamrezaei F, Kariman N, Ghasemi F. Autologous platelet-rich plasma for vulvovaginal atrophy and dyspareunia in postmenopausal women: A systematic review and meta-analysis. Complement Ther Clin Pract. 2024 Feb;55:101783. doi: 10.1016/j.ctcp.2023.101783. Epub 2023 Nov 17. PMID: 38048995.
* Fiala C, Kloss S, Hirtler L, Oburu M, Gruber D, Feichtinger M. Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Therapies for Genitourinary Syndrome of Menopause: A Narrative Review. Cells. 2023 Jan 25;12(3):403. doi: 10.3390/cells12030403. PMID: 36766627; PMCID: PMC9913125.
* Litschauer B, Fiala C, Hirtler L, Feichtinger M, Oburu M, Gruber D, Kloss S. A Prospective, Single-Center Pilot Study to Evaluate the Efficacy and Safety of Intra-Vaginal Platelet-Rich Plasma Injections in Women with Dyspareunia Due to Genitourinary Syndrome of Menopause. Biomedicines. 2023 Feb 15;11(2):595. doi: 10.3390/biomedicines11020595. PMID: 36830999; PMCID: PMC9953258.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.